deltatrials
Unknown PHASE4 NCT00140257

DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome

A Double-Blind, Placebo-Controlled Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome

Sponsor: Bispebjerg Hospital

Conditions Depression
Interventions Escitalopram
Updated 5 times since 2017 Last updated: Dec 30, 2008 Started: Nov 30, 2004 Primary completion: Dec 31, 2008

A PHASE4 clinical study on Depression, this trial is ongoing. The trial is conducted by Bispebjerg Hospital and has accumulated 5 data snapshots since 2004. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    First recorded

Nov 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bispebjerg Hospital
  • Danish Heart Foundation
  • H. Lundbeck A/S
  • The Danish Medical Research Council
Data source: Bispebjerg Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Copenhagen, Denmark